CCM
MGNX icon

Consonance Capital Management’s MacroGenics MGNX Stock Holding History

Consonance Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,472,447
Closed -$78.7M – 36
2021
Q1 		$78.7M Buy
2,472,447
+172,618
+8% +$4.19M 8.39% 3
2020
Q4 		$52.6M Sell
2,299,829
-1,447,469
-39% -$33.3M 4.91% 10
2020
Q3 		$94.4M Sell
3,747,298
-294,237
-7% -$8.03M 11.5% 1
2020
Q2 		$113M Buy
+4,041,535
New +$70.2M 6.76% 3

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Consonance Capital Management's MGNX Position: Q2 2021 in Review

Consonance Capital Management sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 2,472,447 shares — an estimated $78.7M sold.

Consonance Capital Management first reported a position in MGNX in Q2 2020 and held it in 4 quarters. The position peaked at $113M in Q2 2020. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Consonance Capital Management reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Consonance Capital Management sold 2,472,447 MacroGenics shares in Q2 2021, an estimated $78.7M.
  • Consonance Capital Management first reported a position in MacroGenics in Q2 2020 and held it in 4 quarters.
  • Consonance Capital Management's MacroGenics position peaked at $113M in Q2 2020.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Consonance Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.